10.1007/s10620-008-0332-9 [DOI] [PubMed] [Google Scholar] Skorjanec S., Kokot A., Drmic D., Radic B., Sever M., Klicek R., et al
A 2025 study published in Obesity Medicine found that patients treated by an obesity specialist were 8 times more likely to persist on GLP-1 therapy than those treated in general care settings
Is BPC-157 FDA approved in 2026
If untreated, the appendix can burst, causing life-threatening complications
Supporting Gut Health on Weight Loss Injections What to eat on GLP-1 also heavily influences your digestive comfort
Independent Wellness offers guidance on both medication paths, and the Semaglutide vs Tirzepatide page can help you understand the differences before your consultation